Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma
about
Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapyMaintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma.Progress in active-specific immunotherapy of brain malignancies.Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiationPharmacotherapy of malignant astrocytomas of children and adults: current strategies and future trends.Therapeutic activity of NK cells against tumors.An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system.Immunotherapeutic treatment strategies for primary brain tumors.Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.Gammadelta T cells as immune effectors against high-grade gliomas.Dendritic cell therapy of high-grade gliomas.No role of IFITM3 in brain tumor formation in vivo.Cytokine networks in glioma.Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.Immunological Aspects of Malignant Gliomas.Zoledronic acid enhances Vδ2 T-lymphocyte antitumor response to human glioma cell lines.IFN-γ and tumor gangliosides: Implications for the tumor microenvironment.
P2860
Q28485036-34067888-0373-4551-B1E9-DB881D809C28Q33371019-4581524A-A016-4F9F-8601-3E3256FB9277Q34075068-F81EE353-ACB5-4086-ADAB-47EF820D2902Q34223630-929DB51B-F363-4FC5-A4C5-88B9E0012548Q34387557-2D8728B0-A70B-49BF-9326-8FAD1570193AQ34552162-A31AF1DA-AF75-43BA-9441-2DB0D0F85CB7Q35781959-92D36076-FF19-4CD8-B046-5B114B18C174Q36115400-4DE3B9F9-7FE3-4434-82BC-CFEDAF385770Q37117689-5DE33692-FB18-4F4A-9C02-0242E7EE4B6BQ37344951-2D5468D0-DA9B-43A9-B0C8-6EBD70262FD7Q37587832-DEAC034B-9EE0-4BD2-B794-E55340BEFCA3Q37594834-36E7347C-944E-44F0-99FD-3A264C635FF1Q37699245-D736B096-47DA-4FD1-B0C9-4DFCD9C407C8Q37886819-32F2BAA7-CD26-443F-AB35-93514FC176F2Q37970682-49BBD058-8864-4DBB-9A68-8B33E952862EQ38227496-FD16D729-138B-457F-B3FA-AC3E249E7F87Q38870994-28BFD4DA-3CE5-4582-A37C-8BEA4C27B5F8Q39558094-BF111043-D7A9-4F40-BDBF-227A9EA5F652Q50867715-923F8800-7241-4593-B9FC-CE44FCE0AF7A
P2860
Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Randomised, controlled study o ...... n newly diagnosed glioblastoma
@ast
Randomised, controlled study o ...... n newly diagnosed glioblastoma
@en
type
label
Randomised, controlled study o ...... n newly diagnosed glioblastoma
@ast
Randomised, controlled study o ...... n newly diagnosed glioblastoma
@en
prefLabel
Randomised, controlled study o ...... n newly diagnosed glioblastoma
@ast
Randomised, controlled study o ...... n newly diagnosed glioblastoma
@en
P2093
P2860
P356
P1476
Randomised, controlled study o ...... n newly diagnosed glioblastoma
@en
P2093
Blomstedt G
Färkkilä M
Jääskeläinen J
Raininko R
Virkkunen P
P2860
P2888
P304
P356
10.1038/BJC.1994.263
P407
P577
1994-07-01T00:00:00Z